Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an...
from NDTV Profit - Latest https://ift.tt/3ptPJMC
from NDTV Profit - Latest https://ift.tt/3ptPJMC
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
![Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients]()
Reviewed by placements page
on
December 30, 2020
Rating:
No comments: